166 related articles for article (PubMed ID: 29389067)
1. Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma.
Amber KT; Valdebran M; Lu Y; De Feraudy S; Linden KG
J Dtsch Dermatol Ges; 2018 Feb; 16(2):196-198. PubMed ID: 29389067
[No Abstract] [Full Text] [Related]
2. Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma.
Schmidgen MI; Butsch F; Schadmand-Fischer S; Steinbrink K; Grabbe S; Weidenthaler-Barth B; Loquai C
J Dtsch Dermatol Ges; 2017 Jul; 15(7):742-745. PubMed ID: 28622432
[No Abstract] [Full Text] [Related]
3. Severe bullous pemphigoid associated with pembrolizumab therapy for metastatic melanoma with complete regression.
Rofe O; Bar-Sela G; Keidar Z; Sezin T; Sadik CD; Bergman R
Clin Exp Dermatol; 2017 Apr; 42(3):309-312. PubMed ID: 28211077
[TBL] [Abstract][Full Text] [Related]
4. Bullous pemphigoid induced by pembrolizumab in a patient with advanced melanoma expressing collagen XVII.
Wada N; Uchi H; Furue M
J Dermatol; 2017 Oct; 44(10):e240-e241. PubMed ID: 28677843
[No Abstract] [Full Text] [Related]
5. A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab.
Carlos G; Anforth R; Chou S; Clements A; Fernandez-PeƱas P
Melanoma Res; 2015 Jun; 25(3):265-8. PubMed ID: 25831416
[TBL] [Abstract][Full Text] [Related]
6. Bullous pemphigoid induced by ipilimumab in a patient with metastatic malignant melanoma after unsuccessful treatment with nivolumab.
Kuwatsuka Y; Iwanaga A; Kuwatsuka S; Okubo Y; Murayama N; Ishii N; Hashimoto T; Utani A
J Dermatol; 2018 Jan; 45(1):e21-e22. PubMed ID: 28944534
[No Abstract] [Full Text] [Related]
7. Nivolumab-associated bullous pemphigoid reactions involving multiple epitopes.
Aoki Y; Miyagawa F; Miyashita K; Nishimura Y; Hashimoto T; Asada H
Eur J Dermatol; 2019 Oct; 29(5):552-554. PubMed ID: 31570326
[No Abstract] [Full Text] [Related]
8. Dupilumab for the treatment of nivolumab-induced bullous pemphigoid: a case report and review of the literature.
Klepper EM; Robinson HN
Dermatol Online J; 2021 Sep; 27(9):. PubMed ID: 34755978
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma.
Mochel MC; Ming ME; Imadojemu S; Gangadhar TC; Schuchter LM; Elenitsas R; Payne AS; Chu EY
J Cutan Pathol; 2016 Sep; 43(9):787-91. PubMed ID: 27161449
[TBL] [Abstract][Full Text] [Related]
10. Severe bullous pemphigoid in a metastatic lung cancer patient treated with pembrolizumab.
Adachi E; Honda T; Nonoyama S; Irie H; Yamamura K; Otsuka A; Kabashima K
J Dermatol; 2019 Jul; 46(7):e232-e233. PubMed ID: 30758879
[No Abstract] [Full Text] [Related]
11. Bullous pemphigoid, an autoantibody-mediated disease, is a novel immune-related adverse event in patients treated with anti-programmed cell death 1 antibodies.
Hwang SJ; Carlos G; Chou S; Wakade D; Carlino MS; Fernandez-Penas P
Melanoma Res; 2016 Aug; 26(4):413-6. PubMed ID: 27031539
[TBL] [Abstract][Full Text] [Related]
12. Late presentation of generalised bullous pemphigoid-like reaction in a patient treated with pembrolizumab for metastatic melanoma.
Parakh S; Nguyen R; Opie JM; Andrews MC
Australas J Dermatol; 2017 Aug; 58(3):e109-e112. PubMed ID: 27170423
[TBL] [Abstract][Full Text] [Related]
13. Inverse Psoriasiform Eruption During Pembrolizumab Therapy for Metastatic Melanoma.
Totonchy MB; Ezaldein HH; Ko CJ; Choi JN
JAMA Dermatol; 2016 May; 152(5):590-2. PubMed ID: 26675815
[No Abstract] [Full Text] [Related]
14. Localized pretibial pemphigoid associated with trichilemmal carcinoma.
Nakatani C; Muramatsu T; Shirai T
J Dermatol; 1998 Jul; 25(7):448-52. PubMed ID: 9714978
[TBL] [Abstract][Full Text] [Related]
15. Bullous pemphigoid in elderly woman affected by non-small cell lung cancer treated with pembrolizumab: A case report and review of literature.
Cosimati A; Rossi L; Didona D; Forcella C; Didona B
J Oncol Pharm Pract; 2021 Apr; 27(3):727-733. PubMed ID: 32772795
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid Syndrome Following Pembrolizumab Treatment of Stage IIIB Unresectable Melanoma.
Sanchez A; Montaudie H; Bory P; Belgodere X; Passeron T; Lacour JP; Picard A
JAMA Dermatol; 2018 Nov; 154(11):1354-1356. PubMed ID: 30326507
[No Abstract] [Full Text] [Related]
17. A case of pembrolizumab-induced localized organizing pneumonia.
Arays R; Wang P
Scand J Immunol; 2018 Jul; 88(1):e12677. PubMed ID: 29856074
[No Abstract] [Full Text] [Related]
18. Pemphigoid and pemphigus foliaceus successfully treated with topical corticosteroids.
Muramatsu T; Iida T; Shirai T
J Dermatol; 1996 Oct; 23(10):683-8. PubMed ID: 8973033
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-predominant bullous pemphigoid induced by checkpoint inhibitors: A case series.
Morris LM; Lewis HA; Cornelius LA; Chen DY; Rosman IS
J Cutan Pathol; 2020 Aug; 47(8):742-746. PubMed ID: 32196722
[TBL] [Abstract][Full Text] [Related]
20. Pembrolizumab-induced polymyalgia rheumatica in two patients with metastatic melanoma.
Garel B; Kramkimel N; Trouvin AP; Frantz C; Dupin N
Joint Bone Spine; 2017 Mar; 84(2):233-234. PubMed ID: 27133763
[No Abstract] [Full Text] [Related]
[Next] [New Search]